Adverse reactions after Covid vaccination: reports on VigiBase total 5.1 million and include more than 25,400 deaths
This article has been updated with the latest EudraVigilance statistics.
The World Health Organisation’s VigiBase now lists 5,115,884 reports of adverse events following Covid vaccination, including 25,495 deaths (listed under ‘General disorders and administration site conditions’).
There is a separate listing, under the same category, of 2,263 reports of sudden death along with 482 reports of sudden cardiac death, 199 reports of brain death, 171 reports of cardiac death, 20 reports of premature baby death, 15 reports of neonatal death, six reports of “clinical death”, five reports of sudden infant death syndrome, and three reports of “sudden unexplained death in epilepsy”.
A total 309,849 reports are about cardiac disorders, 232,225 are about vascular disorders, and 220,431 are about blood and lymphatic system disorders.
There are 271,221 reproductive system and breast disorders listed and 13,395 reports of “pregnancy, peurperium (postpartum), and perinatal conditions”.
There are 7,728 reports of Guillain-Barré syndrome, 11,744 reports of Bell’s palsy, 17,039 cases categorised as facial paralysis, and 4,958 reports of facial paresis.
A total 28,532 cases of myocarditis are listed along with 23,323 cases of pericarditis and 3,495 cases of myopericarditis.
The statistics were updated on July 16.
EudraVigilance
EudraVigilance now lists 2,251,877 adverse reaction cases reported after the administration of Covid vaccines in Europe. The data is up to July 17, 2023.
The database lists 1,229,379 individual cases up to July 17 for the Pfizer-BioNTech vaccine tozinameran. Most are from Germany (218,606), followed by France (129,570), and the Netherlands (125,801).
A total 5,961 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, riltozinameran) that targets the original strain of SARS-CoV-2, which is no longer circulating, and the Omicron BA.1 subvariant, which has been de-escalated by the European Centre for Disease Prevention and Control. Most cases are from the Netherlands (2,211), followed by Belgium (371), and Germany (239).
A total 8,929 cases are listed for the Pfizer-BioNTech bivalent booster vaccine (tozinameran, famtozinameran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Most cases are from Germany (1,413), followed by Spain (1,095), and France (749).
A total 548,047 cases are listed for the AstraZeneca-Oxford vaccine with the most listed in Germany (54,814), followed by Austria (41,286), and the Netherlands (38,022).
A total 377,798 cases are listed for the Moderna vaccine (elasomeran). Most are from Germany (65,739), followed by the Netherlands (49,858), and France (34,326).
A total 7,820 cases are listed for the Moderna bivalent booster vaccine (elasomeran, imelasomeran) that targets the original strain of SARS-CoV-2 and the BA.1 subvariant. Most are from the Netherlands (3,607), followed by Spain (73), and France (56).
A total 615 cases are listed for the Moderna bivalent booster vaccine (elasomeran, davesomeran) that targets the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 subvariants. Twenty-two cases are listed for Germany, 19 for France, and 12 for Norway, along with ten cases in Ireland, eight in Italy, and four in the Netherlands, but further data for individual countries is not provided.
A total 71,309 cases are listed for the Janssen Biotech vaccine. Most are from the Netherlands (15,099), followed by Germany with 12,141, and Austria (11,214).
A total 1,623 cases are now listed for the Novavax vaccine. Most are from Germany (1,004), followed by Italy with 159 cases, and France with 120.
A total 34 cases are listed for the Valneva vaccine. Eighteen cases are listed for Germany, 11 for Austria, and five for Italy.
A total 362 cases are reported for the VidPrevtyn Beta vaccine, developed by Sanofi Pasteur. Nine cases were reported in France, but the location of the other cases isn’t given.
The European Medicines Agency (EMA) states on its website that, by the end of May 2023, there had been nearly 1.7 million “spontaneous reports of suspected side effects, which translates into about 0.2 spontaneous reports for every 100 administered vaccine doses”.
It adds that there had been nearly 12,000 “spontaneous reports of fatal outcomes in the EU and EEA, which translates into about 0.001 reported fatal outcomes for every 100 administered vaccine doses”.
Nearly 768 million Covid vaccine doses had been administered in European Union and European Economic Area countries by the end of May 2023, the EMA added.
There is more detail about these statistics on my Changing Times website along with data from other adverse event databases.
The World Health Organisation updates its VigiBase data every Sunday.
The EudraVigilance data are usually updated on Mondays.
See my July 15 Substack article for the latest VAERS data.